Vaccine Market to Reach $77.5 Billion by 2024 | Presence of Several Pipeline Dugs to lead the Growth of the Vaccine Industry
The global Vaccine Market was valued at over USD 32.5 billion in 2015 and is expected to grow at a CAGR of 10.3% over the forecast period.
(firmenpresse) - The global vaccine market size valuation is expected to exceed USD 77.5 billion by 2024, at a CAGR of 10.3% according to a new report by Grand View Research, Inc. Development of various molecules to cater to the growing demand for vaccines can drive market demand. Majority of the key players are focused on vaccine development to gain an edge over competitors. For instance, Pfizer, Inc., is developing vaccines for Clostridium difficile, Staphylococcus aureus, and Meningococcal B.
Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate the market growth.
For instance, the nsive immunization coverage on the Indian continent is the National Immunization Program, a government program that has focused on taking strong preventive measures to offset vaccine-preventable diseases, particularly in children.
Further key findings from the study suggest:
ccine in India.
sociated are ease of production, long lasting immunogenicity, and no risk of reversion.
s.
e low manufacturing operations cost provide a platform for clinical trial outsourcing of the vaccinations under development to expedite commercialization.
& Co., Inc., Emergent BioSolutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., and GlaxoSmithKline Plc. Other prominent players include Abbott Laboratories, Inc., AstraZeneca plc, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals International, Inc.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com
Datum: 22.03.2020 - 04:08 Uhr
Sprache: Deutsch
News-ID 1556973
Anzahl Zeichen: 3986
contact information:
Contact person:
Town:
San Francisco
Phone: 1-888-202-9519
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 20.03.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 848 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Vaccine Market to Reach $77.5 Billion by 2024 | Presence of Several Pipeline Dugs to lead the Growth of the Vaccine Industry
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
